Literature DB >> 18184914

From gonocytes to testicular cancer: the role of impaired gonadal development.

Ewa Rajpert-de Meyts1, Christina E Hoei-Hansen.   

Abstract

Testicular germ-cell tumors occur primarily in young individuals, and the tumors in this age group (seminomas or nonseminomas) are derived from a preinvasive precursor cell called carcinoma in situ (CIS) or intratubular germ-cell neoplasia. These tumors have been a growing problem, especially in highly developed industrialized countries. A hypothesis was put forward that CIS originates from arrested fetal germ cells, thus testicular cancer is a developmental disease of germ-cell differentiation. This notion was supported by comparative studies of the gene expression at the protein and RNA level, which demonstrated a close similarity of CIS to primordial germ cells and gonocytes with many features of embryonic stem cells. The arrest of germ-cell differentiation is thus the key first event, which may be followed by malignant transformation and overt germ-cell cancer in young adult age, usually after puberty. In most cases the arrest/delay of germ-cell differentiation is caused by testicular dysgenesis, a multifactorial and complex syndrome that has a broad spectrum of phenotypes ranging from moderate impairment of spermatogenesis to severe disorders of sexual development and differentiation. The most severe cases are a result of inherited genetic aberrations, but the etiology of the common sporadic testicular cancer must involve environmental factors, including maternal lifestyle and possibly an early exposure to endocrine disruptors. The effects of environmental factors are likely modulated by genomic variation (polymorphisms), thus explaining the individual susceptibility and population-level differences in the incidence of testicular cancer.

Entities:  

Mesh:

Year:  2007        PMID: 18184914     DOI: 10.1196/annals.1411.013

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

Review 1.  Testicular germ cell tumours: predisposition genes and the male germ cell niche.

Authors:  Duncan Gilbert; Elizabeth Rapley; Janet Shipley
Journal:  Nat Rev Cancer       Date:  2011-03-17       Impact factor: 60.716

2.  Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo.

Authors:  Martin Blomberg Jensen; Anne Jørgensen; John Erik Nielsen; Andreas Steinmeyer; Henrik Leffers; Anders Juul; Ewa Rajpert-De Meyts
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

3.  Congenital malformations and testicular germ cell tumors.

Authors:  Britton Trabert; Daniela Zugna; Lorenzo Richiardi; Katherine A McGlynn; Olof Akre
Journal:  Int J Cancer       Date:  2013-05-15       Impact factor: 7.396

4.  Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer.

Authors:  Peter A Kanetsky; Nandita Mitra; Saran Vardhanabhuti; Mingyao Li; David J Vaughn; Richard Letrero; Stephanie L Ciosek; David R Doody; Lauren M Smith; Joellen Weaver; Anthony Albano; Chu Chen; Jacqueline R Starr; Daniel J Rader; Andrew K Godwin; Muredach P Reilly; Hakon Hakonarson; Stephen M Schwartz; Katherine L Nathanson
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

5.  Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors.

Authors:  Roelof Koster; Nandita Mitra; Kurt D'Andrea; Saran Vardhanabhuti; Charles C Chung; Zhaoming Wang; R Loren Erickson; David J Vaughn; Kevin Litchfield; Nazneen Rahman; Mark H Greene; Katherine A McGlynn; Clare Turnbull; Stephen J Chanock; Katherine L Nathanson; Peter A Kanetsky
Journal:  Hum Mol Genet       Date:  2014-06-18       Impact factor: 6.150

Review 6.  Male reprotoxicity and endocrine disruption.

Authors:  Sarah Campion; Natasha Catlin; Nicholas Heger; Elizabeth V McDonnell; Sara E Pacheco; Camelia Saffarini; Moses A Sandrof; Kim Boekelheide
Journal:  Exp Suppl       Date:  2012

7.  An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism.

Authors:  Hussein Ajj; Amand Chesnel; Sophie Pinel; François Plenat; Stephane Flament; Helene Dumond
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

8.  Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testes.

Authors:  Vittoria Rago; Francesco Romeo; Francesca Giordano; Marcello Maggiolini; Amalia Carpino
Journal:  Reprod Biol Endocrinol       Date:  2011-10-05       Impact factor: 5.211

9.  OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia.

Authors:  Jasmine Lim; Anne Goriely; Gareth Dh Turner; Katherine A Ewen; Grete Krag Jacobsen; Niels Graem; Andrew Om Wilkie; Ewa Rajpert-De Meyts
Journal:  J Pathol       Date:  2011-06-27       Impact factor: 7.996

10.  Identification of ERbeta1 and ERbeta2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia.

Authors:  Vittoria Rago; Francesco Romeo; Francesca Giordano; Aurora Ferraro; Sebastiano Andò; Amalia Carpino
Journal:  Reprod Biol Endocrinol       Date:  2009-06-03       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.